Weight gain stopping/switch rules for antiretroviral clinical trials

AIDS. 2022 Jun 1;36(7):1053-1054. doi: 10.1097/QAD.0000000000003221.

Authors

Vinie Kouamou¹, Seth Inzaule², Justen Manasa¹

Affiliations

¹ University of Zimbabwe, Harare, Zimbabwe.
² Amsterdam Institute for Global Health and Development, UMC, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 35652678
DOI: 10.1097/QAD.0000000000003221

No abstract available

Publication types

Comment

MeSH terms

Anti-Retroviral Agents / therapeutic use
HIV Infections* / drug therapy
Humans
Weight Gain

Substances

Anti-Retroviral Agents